Please read this entire section if you decide to take this course.  It is a requirement for CE Credit.

Course Overview

This dual-credit course meets the requirements for 1.5 hours of preceptor CE as well as 1 hour of opioid abuse training.  Participants will receive a total of 1.5 hours CE credit upon completion of the course.

Target Audience

 

Pharmacists

 

Activity Accreditation                                                                         Type: Knowledge

ACPE - Pharmacists Accreditation
Credit Hours: 1.5 CE        
ACPE UAN: 0834-0000-19-045-H04-P                                                                                                                                  Expiration Date: 09/30/2021             Release Date: 10/18/19

 

 

TAMHSC-CBHEC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

The Home study activity, “The Role of Pharmacist in the Opioid Crisis and Ways Preceptors Can Engage Students in the Process” has been accredited for up to 1.5 contact hours of ACPE continuing pharmacy education.

 

In order to receive CE credit, the following activities must be successfully completed:

1)  Reading the Learning Objectives and Disclosures of planners and faculty,
2)  Completing the educational online course activity in its entirety,
3)  Completing the Course Evaluation activity,
4)  Completing the self-assessments with a score of 70%.

 

ACPE UAN: 0834-0000-19-045-H04-P 

CE credit will be submitted to the NABP-CPE Monitor within 30 days. It is recommended that you check your NABP CPE Monitor e-profile database 30 days after the completion of any CE activity to ensure that your credits are posted.

 

NABP e-PROFILE ID NUMBER: to receive credit for your participation in this activity, all pharmacists must include their NABP e-Profile ID number, along with their month and date of birth. If incorrect information is provided, this will result in "rejected" status from the CPE Monitor. It is the responsibility of the participant to notify Texas A&M Irma Lerma Rangel College of Pharmacy (within the 60 day submission time frame) of their corrected information. Otherwise, the completed CE will not be accepted by the CPE Monitor.

 

Faculty

Speaker

Joy Alonzo, M.Engineering, PharmD 
Clinical Assistant Professor
Texas A&M University College of Pharmacy
MHBH Support Specialist
Director Spring Outreach Services Mental/Behavioral Health Support

 

Learning Objectives:  1) Discuss several ways that pharmacists can engage in prevention and education for patients and primary care providers regarding opioids.  2) Describe best practices to monitor opioid use in the community and health system pharmacy.  3) Examine the naloxone standing order and the use of naloxone rescue kits for reversing an opioid overdose.  4) Engage pharmacy students in factors influencing the opioid use, misuse, diversion, and strategies to avert.

 

Speaker Bio

Dr. Alonzo received her BS degree in Pharmacy from the University of Pittsburgh, her Masters of Engineering from the Penn State, and her doctoral degree in Pharmacotherapy and Pharmacy Practice from Howard University in 
Washington, D.C. 
Dr. Alonzo is a specialist in the pharmacotherapy of mental and behavioral disorders and provides clinical support to mental and behavioral clinicians and facilities across Texas.  Dr. Alonzo is currently Clinical Assistant Professor, Department of Pharmacy Practice, Texas A&M Health Science Center Rangel College of Pharmacy, Director of Spring Outreach Services Mental and Behavioral Support, and a member of the Texas A&M Opioid Task Force. 

 

Faculty and Planner Disclosure - Policies and standards of the Accreditation Council for Pharmacy Education require that faculty and planners for continuing pharmacy education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CPE activity. Conflicts of interest are created when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CPE about products and/or services of commercial interest. Therefore, a conflict of interest form is obtained from all persons in control of CPE content. 

 

J.P. Alonzo, M.Engineering, PharmD has no relevant financial relationships to disclose

 

The Course Director and following participating Faculty Planners have no relevant financial relationships to disclose.

 

Course Director:

 

Asim Abu-Baker, PharmD
Clinical Professor for Pharmacy Practice
Associate Dean for Clinical and Professional Affairs
Interim Department Head of Pharmacy Practice
Texas A&M Irma Lerma Rangel College of Pharmacy, Kingsville, TX

 

Faculty Planners:

 

Carolynn Mathews, B.S. Pharm
Director of Experiential Education
Texas A&M Irma Lerma Rangel College of Pharmacy, Kingsville,TX

 

Off-Label Product Discussion

 

In accordance with ACPE Criteria for Quality, the audience is advised that authors in this CPE activity may include reference(s) to unlabeled, unapproved, or investigational uses of therapeutic agents or biomedical devices. The authors will inform the reader of when they discuss or reference an unapproved, unlabeled, or investigational use of a therapeutic agent or biomedical device.

 

University Disclosure

 

The opinions and recommendations expressed by faculty and other experts are their own. This activity is produced for educational purposes only. Use of the names of The Texas A&M Irma Lerma Rangel College of Pharmacy and Coastal Bend Health Education Center implies review of educational format, design and approach.  These materials may discuss use and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

 

For technical or other issues, please contact:

Dr. Janice Meyer, Program Manager
Email: janice.meyer@tamu.edu
Telephone: 979-458-2511

Basic Computer Specifications for Canvas

Screen Size - Canvas is best viewed at a minimum resolution of 800x600. If you want to view Canvas on a device with a smaller screen, we recommend using the Canvas mobile app.

Operating Systems  - Windows 7 and newer/Mac OSX 10.6 and newer / Linux - chromeOS

Mobile Operating System Native App Support - iOS 7 and newer (versions vary by device) / Android 4.2 and newer

Computer Speed and Processor - Use a computer 5 years old or newer when possible / 1GB of RAM/2GHz processor

Internet Speed - Along with compatibility and web standards, Canvas has been carefully crafted to accommodate low bandwidth environments/ Minimum of 512kbps